ACQUISITION OF BRUCELLA MELITENSIS REV-1 VACCINE CONJUNCTIVAL APPLICATION (BOX OF 50 DOSES)

This tender concerns the acquisition of the Brucella Melitensis Rev-1 vaccine, specifically formulated for conjunctival application and supplied in boxes of 50 doses. The procurement is being managed by the Servicio Nacional de Sanidad Agraria (SENASA), the National Agrarian Health Service. This is an international procurement process, identified by the reference number INTER-PROC-1-2026-SENASA-1. The vaccine is intended for use in the department of Lima. Brucellosis is a significant zoonotic disease affecting livestock, and the Rev-1 strain of Brucella melitensis is commonly used in vaccination programs to control its spread, particularly in small ruminants like sheep and goats. The conjunctival route of administration is a specific requirement, suggesting a particular application method or protocol being followed by SENASA. This tender is crucial for SENASA's ongoing efforts to maintain animal health and prevent the transmission of brucellosis within the agricultural sector. The international nature of the contract indicates that bids from foreign suppliers are expected, and adherence to international procurement standards will be paramount. The successful bidder will be responsible for the supply of this specialized veterinary biological product, ensuring its quality, efficacy, and timely delivery to meet the public health and agricultural safety objectives of Peru.

This is a supplies contract in the governance and public administration sector. Located in Peru, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of PEN 23,556.

Published through Peru SEACE, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the governance and public administration sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.